BridgeBio Oncology Therapeutics Inc. (BBOT) vs Vanda Pharmaceuticals Inc. (VNDA)
A side-by-side comparison of BridgeBio Oncology Therapeutics Inc. and Vanda Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBOT
BridgeBio Oncology Therapeutics Inc.
$3.54HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
VNDA
Vanda Pharmaceuticals Inc.
$4.50HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — BBOT vs VNDA
growth of $100 · dividends reinvested · last 3yBBOT -64.7% (-29.3%/yr)VNDA +26.2% (+8.1%/yr)VNDA compounded faster over this window
BBOT VNDA
BBOT vs VNDA: by the numbers
- •BBOT is the larger company ($283M vs $270M market cap).
- •Both run net losses; BBOT's is the smaller (0.00% vs -127.41% net margin).
Metrics side by side
Valuation
| Metric | BBOT | VNDA |
|---|---|---|
| P/S ratio | N/A | 1.25 |
| P/B ratio | 0.88 | 1.23 |
Profitability
| Metric | BBOT | VNDA |
|---|---|---|
| Gross margin | 0.00% | 92.82% |
| Operating margin | 0.00% | -69.95% |
| Net margin | 0.00% | -127.41% |
| ROE | -56.36% | -124.83% |
| ROIC | -61.10% | -74.73% |
Growth (annualized)
| Metric | BBOT | VNDA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -3.56% |
| Total return CAGR (5Y) | N/A | -23.91% |
Go deeper
Dig into the metrics
BridgeBio Oncology Therapeutics ROEVanda Pharmaceuticals ROEBridgeBio Oncology Therapeutics operating marginVanda Pharmaceuticals operating marginBridgeBio Oncology Therapeutics revenue growthVanda Pharmaceuticals revenue growthBridgeBio Oncology Therapeutics free cash flowVanda Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.